Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national
7
×
national blog main
national top stories
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
medicare
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
president trump
drug prices
fda
pfizer
regeneron pharmaceuticals
abbvie
alex azar
alexion pharmaceuticals
alzheimer's disease
astrazeneca
biogen
bristol-myers squibb
What
drug
prices
7
×
plan
bio
long
lower
prescription
roundup
alzheimer’s
awaited
blueprint
details
drugs
gene
house
medicare
pharmaceutical
trump
administration
afternoon
anathema
announced
annual
anticipated
aren’t
assessed
attention
away
biopharma
biotech
bringing
ceos
cheaper
communities
companies
conference
cost
cut
dc
democrat
Language
unset
Current search:
national
×
prices
×
@xconomy.com
4 years ago
After First Look at House Drug Plan, Stocks Rise Slightly
@xconomy.com
5 years ago
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
Trump Plan Ties Medicare Drug Prices to Cheaper Foreign Ones
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More
@xconomy.com
5 years ago
Trump Pledges Lower Drug Prices, But Blueprint Is Short on Details